GB9606614D0 - Method for treating obsessive-compulsive disorder - Google Patents

Method for treating obsessive-compulsive disorder

Info

Publication number
GB9606614D0
GB9606614D0 GBGB9606614.7A GB9606614A GB9606614D0 GB 9606614 D0 GB9606614 D0 GB 9606614D0 GB 9606614 A GB9606614 A GB 9606614A GB 9606614 D0 GB9606614 D0 GB 9606614D0
Authority
GB
United Kingdom
Prior art keywords
compulsive disorder
treating obsessive
obsessive
treating
compulsive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9606614.7A
Other versions
GB2305859A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to GB9606614A priority Critical patent/GB2305859A/en
Publication of GB9606614D0 publication Critical patent/GB9606614D0/en
Publication of GB2305859A publication Critical patent/GB2305859A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GB9606614A 1996-03-29 1996-03-29 Treatment of obsessive-compulsive disorder Withdrawn GB2305859A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9606614A GB2305859A (en) 1996-03-29 1996-03-29 Treatment of obsessive-compulsive disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9606614A GB2305859A (en) 1996-03-29 1996-03-29 Treatment of obsessive-compulsive disorder

Publications (2)

Publication Number Publication Date
GB9606614D0 true GB9606614D0 (en) 1996-06-05
GB2305859A GB2305859A (en) 1997-04-23

Family

ID=10791245

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9606614A Withdrawn GB2305859A (en) 1996-03-29 1996-03-29 Treatment of obsessive-compulsive disorder

Country Status (1)

Country Link
GB (1) GB2305859A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783516B2 (en) * 2001-04-30 2005-11-03 Warner-Lambert Company Methods, kits and compositions for using pyrrole derivatives

Also Published As

Publication number Publication date
GB2305859A (en) 1997-04-23

Similar Documents

Publication Publication Date Title
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) Method for treating pain
ZA973707B (en) Method for treating inflammation.
IL126064A0 (en) Method for treating pain
GB9605828D0 (en) Treatment method
IL125031A0 (en) Method for treating depression
PL328964A1 (en) Acne treating method
IL124786A0 (en) Method for treating pain
EG23945A (en) Method for treating COPD
IL126162A0 (en) Method for treating bipolar disorder
ZA971899B (en) Method for treating insomnia
GB9606614D0 (en) Method for treating obsessive-compulsive disorder
EP1043994A4 (en) Method for treating multiple sclerosis
SI0667175T1 (en) Method for treating edges of skis etc.
IL126160A0 (en) Method for treating insomnia
GB9606619D0 (en) Method for treating bipolar disorder
GB9606616D0 (en) Method for treating autism
IL139506A0 (en) Method for treating autism
GB9606731D0 (en) Method for treating insomnia
GB9606617D0 (en) Method for treating substance abuse
GB9614742D0 (en) Treatment method
GB9614743D0 (en) Treatment method
GB9600610D0 (en) Treatment method
GB9614741D0 (en) Treatment method
GB9606620D0 (en) Method for treating excessive aggression

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)